212 related articles for article (PubMed ID: 26690929)
21. Copper catalyzed oxidation of Alzheimer Abeta.
Atwood CS; Huang X; Khatri A; Scarpa RC; Kim YS; Moir RD; Tanzi RE; Roher AE; Bush AI
Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):777-83. PubMed ID: 10875439
[TBL] [Abstract][Full Text] [Related]
22. DNA binding, nuclease activity, DNA photocleavage and cytotoxic properties of Cu(II) complexes of N-substituted sulfonamides.
García-Giménez JL; Hernández-Gil J; Martínez-Ruíz A; Castiñeiras A; Liu-González M; Pallardó FV; Borrás J; Alzuet Piña G
J Inorg Biochem; 2013 Apr; 121():167-78. PubMed ID: 23384854
[TBL] [Abstract][Full Text] [Related]
23. Free Superoxide is an Intermediate in the Production of H2O2 by Copper(I)-Aβ Peptide and O2.
Reybier K; Ayala S; Alies B; Rodrigues JV; Bustos Rodriguez S; La Penna G; Collin F; Gomes CM; Hureau C; Faller P
Angew Chem Int Ed Engl; 2016 Jan; 55(3):1085-9. PubMed ID: 26629876
[TBL] [Abstract][Full Text] [Related]
24. Transfer of Copper from an Amyloid to a Natural Copper-Carrier Peptide with a Specific Mediating Ligand.
Nguyen M; Bijani C; Martins N; Meunier B; Robert A
Chemistry; 2015 Nov; 21(47):17085-90. PubMed ID: 26420347
[TBL] [Abstract][Full Text] [Related]
25. An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species.
Young TR; Kirchner A; Wedd AG; Xiao Z
Metallomics; 2014 Mar; 6(3):505-17. PubMed ID: 24493126
[TBL] [Abstract][Full Text] [Related]
26. Copper(II) partially protects three histidine residues and the N-terminus of amyloid-β peptide from diethyl pyrocarbonate (DEPC) modification.
Friedemann M; Tõugu V; Palumaa P
FEBS Open Bio; 2020 Jun; 10(6):1072-1081. PubMed ID: 32255544
[TBL] [Abstract][Full Text] [Related]
27. Structural analysis of copper(I) interaction with amyloid β peptide.
De Gregorio G; Biasotto F; Hecel A; Luczkowski M; Kozlowski H; Valensin D
J Inorg Biochem; 2019 Jun; 195():31-38. PubMed ID: 30884319
[TBL] [Abstract][Full Text] [Related]
28. A Trishistidine Pseudopeptide with Ability to Remove Both Cu
Conte-Daban A; Boff B; Candido Matias A; Aparicio CNM; Gateau C; Lebrun C; Cerchiaro G; Kieffer I; Sayen S; Guillon E; Delangle P; Hureau C
Chemistry; 2017 Dec; 23(67):17078-17088. PubMed ID: 28846165
[TBL] [Abstract][Full Text] [Related]
29. Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?
De Ricco R; Valensin D; Dell'Acqua S; Casella L; Hureau C; Faller P
Chembiochem; 2015 Nov; 16(16):2319-28. PubMed ID: 26338312
[TBL] [Abstract][Full Text] [Related]
30. Coordination abilities of a fragment containing D1 and H12 residues of neuropeptide gamma and products of metal-catalyzed oxidation.
Kowalik-Jankowska T; Jankowska E; Kasprzykowski F
Inorg Chem; 2010 Mar; 49(5):2182-92. PubMed ID: 20121248
[TBL] [Abstract][Full Text] [Related]
31. Importance of dynamical processes in the coordination chemistry and redox conversion of copper amyloid-beta complexes.
Hureau C; Balland V; Coppel Y; Solari PL; Fonda E; Faller P
J Biol Inorg Chem; 2009 Sep; 14(7):995-1000. PubMed ID: 19618220
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of human serum albumin on Cu-induced Aβ(40) aggregation and toxicity.
Lu N; Yang Q; Li J; Tian R; Peng YY
Eur J Pharmacol; 2015 Nov; 767():160-4. PubMed ID: 26463036
[TBL] [Abstract][Full Text] [Related]
33. Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer's disease.
Nguyen M; Robert A; Sournia-Saquet A; Vendier L; Meunier B
Chemistry; 2014 May; 20(22):6771-85. PubMed ID: 24797103
[TBL] [Abstract][Full Text] [Related]
34. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
Furlan S; Hureau C; Faller P; La Penna G
J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
[TBL] [Abstract][Full Text] [Related]
35. Key roles of Arg(5), Tyr(10) and his residues in Aβ-heme peroxidase: relevance to Alzheimer's disease.
Lu N; Li J; Tian R; Peng YY
Biochem Biophys Res Commun; 2014 Sep; 452(3):676-81. PubMed ID: 25193696
[TBL] [Abstract][Full Text] [Related]
36. Molecular Simulations of Human and Mouse Aβ1-16 at Different pH Values: Structural Characteristics toward Understanding Cu(2+) -Coordinated Amyloid Beta Spheres.
Zhang R; Ai H; Zhu X; Li Q
Chemphyschem; 2016 Jun; 17(11):1656-68. PubMed ID: 26928943
[TBL] [Abstract][Full Text] [Related]
37. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
[TBL] [Abstract][Full Text] [Related]
38. Electrochemical and conformational consequences of copper (Cu(I) and Cu(II)) binding to beta-amyloid(1-40).
Brzyska M; Trzesniewska K; Wieckowska A; Szczepankiewicz A; Elbaum D
Chembiochem; 2009 Apr; 10(6):1045-55. PubMed ID: 19263448
[TBL] [Abstract][Full Text] [Related]
39. Chemical pathways of peptide degradation: IX. Metal-catalyzed oxidation of histidine in model peptides.
Khossravi M; Borchardt RT
Pharm Res; 1998 Jul; 15(7):1096-102. PubMed ID: 9688066
[TBL] [Abstract][Full Text] [Related]
40. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.
Dikalov SI; Vitek MP; Mason RP
Free Radic Biol Med; 2004 Feb; 36(3):340-7. PubMed ID: 15036353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
